Showing results (101-110 of 261) with videos related to
Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infectionErika Assarsson, John Sidney, Carla Oseroff, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
Ets-1 maintains IL-7 receptor expression in peripheral T cellsRoland Grenningloh, Tzong-Shyuan Tai, Nicole Frahm, et al.Emerging Microbes & Infections|July 23, 2024
Biotech's role in advancing HIV vaccine developmentRoger Tatoud, Christian Brander, Carey Hwang, et al.Antiviral Research|May 29, 2018
Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signaturesSandra Franco, Daniela Buccione, Raquel Pluvinet, et al.Journal of Virology|January 31, 2023
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological DysfunctionClara Duran-Castells, Anuska Llano, Ai Kawana-Tachikawa, et al.Plos One|April 6, 2011
Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequencesMorgane Rolland, Nicole Frahm, David C Nickle, et al.AIDS (London, England)|April 3, 2004
Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panelsRika Draenert, Christian Brander, Xu G Yu, et al.Journal of Virology|September 11, 2015
Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef FunctionAniqa Shahid, Alex Olvera, Gursev Anmole, et al.Journal of Virology|June 8, 2007
Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunctionDiana M Brainard, Andrew M Tager, Joseph Misdraji, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2018
Zip6 Transporter Is an Essential Component of the Lymphocyte Activation MachineryNatalia Colomar-Carando, Alberto Meseguer, Iván Company-Garrido, et al.Pageof 27